Hi all, I just registered because I'm a newbie and confused about what I'm seeing here. It'd be nice for to have my math checked out on this ticker.
OTCMarkets is showing 1,204,383,890 OS as of 3/1/18. To be conservative let's assume that's all float, assume that the 3.7 mil in revenue is all this company will make the whole year, and assume a 1:1 PE valuation. Insanity, but:
3,700,000 / 1,204,383,890 = .00307
That's ULTRA conservative, pure baseline, but about in line with where we're trading now.
Assuming the buyback is happening per their announcement (and Dan doesn't want to go to prison). Still to be conservative, we'll assume that all of the OS is float, and 3.7 mil is all the company will make with a 1:1 PE valuation.
3,700,000 / 240,876,778 = .01536
Thinking realistically that no CBD/Hemp stock trades at a 1:1 PE valuation, the purchase orders for January and February aren't likely to be the only revenue for the whole year, and it's not likely that all of the existing outstanding shares are in the float, that .015 still looks wildly undervalued.
I'm thinking .05 or better once this one starts getting some real attention, and that still seems low compared to other CBD plays. Can someone tell me where my thinking is off on this?